Back

Hope springs eternal: are we yet ready for a novel paradigm shift in lipid-lowering therapy in primary prevention?

European Journal of Preventive Cardiology

10 April 2024
Organised by: Logo
Read full article
ESC Journals

Contributors

Marc L De Buyzere
Marc L De Buyzere

Author

University Hospital Ghent Gent , Belgium

You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
11 April 2024
thumbnail
Congress Presentation
Addressing the unmet needs in LDL-c lowering: what can we expect?
26 August 2022
thumbnail
Congress Presentation
NATURE-LEGACY: Long term legacy benefit of Lowering LDL and SBP
1 September 2025
thumbnail
Webinar
Update of the 2019 ESC Guidelines on Management of Dyslipidaemia: new recommendations and their impact on clinical practice
25 November 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources